NRx Pharmaceuticals Inc. (NRXPW)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue - - - - - - -
Cost of Revenue 5.00K 4.00K 2.00K 907.41K - 1.01M -
Gross Profit -5.00K -4.00K -2.00K -907.41K - -1.01M -
Operating Income -27.59M -44.40M -115.80M -51.39M -6.26K -1.01M -
Interest Income 494.00K 249.00K 18.00 56.00 1.21M 1.09M -
Pretax Income -30.16M -39.82M -93.06M -51.78M 492.63K 82.41K -105.03K
Net Income -30.15M -35.23M -71.72M -12.35M 408.43K 66.10K -105.03K
Selling & General & Admin 14.21M 27.37M 74.94M 11.44M 2.77K 1.01M -
Research & Development 13.37M 17.03M 20.26M 10.63M 3.50K - -
Other Expenses - -505.00K -771.00K -10.16M 713.19K 1.01M -
Operating Expenses 27.58M 44.40M 94.43M 11.90M 6.43K 1.01M -
Interest Expense 120.00K - 18.00K 56.00K - - -
Selling & Marketing Expenses -5.00K - - - - - -
Cost & Expenses 27.59M 44.40M 94.43M 11.90M 6.43K 1.01M -
Income Tax -9.00K -4.58M -21.35M -39.43M 84.21K 16.31K -
Shares Outstanding (Basic) 7.58M 65.77M 46.92M 34.27M 508.83K 892.50K 903.55K
Shares Outstanding (Diluted) 7.58M 65.77M 46.92M 34.27M 508.83K 892.50K 903.55K
EPS (Basic) -3.98 -0.54 -1.53 -0.36 0.80 0.07 -0.12
EPS (Diluted) -3.98 -0.54 -1.53 -0.36 0.80 0.07 -0.12
EBITDA -30.02M -39.75M -93.04M -51.72M -713.19K 82.41K -105.04K
Depreciation & Amortization 5.00K 4.00K 2.00K 2.00K 0.86 1.09M 52.52K